Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on ...
The technology has some promising applications, but is not ready for whole body cancer screening and will not replace other ...
The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...
Introduction In 2021, globally, cardiometabolic diseases (CMDs) accounted for 35% of the 1.73 billion disability-adjusted life years (DALYs) attributed to non-communicable diseases. The Healthy Life ...